// App-Quantinova.ai

PB/LB03 : Differences in Outcomes between Real-World vs Clinical Trial in Atrial Fibrillation and Chronic Kidney Disease

Researchers

Presenter

  • W.Y. Ding

Principal Investigators

  • J.M.R. Caravaca

  • V. Roldn

  • G.Y.H. Lip

Medical Centers

  • Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

  • Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain

  • Hospital General Universitario Morales Meseguer, University of Murcia, Murcia, Spain

  • Aalborg Thrombosis Research Uni, Aalborg University, Aalborg, Denmark

Locations

  • United Kingdom

  • Spain

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Chronic kidney disease

  • Myocardial infarction

  • Arrhythmia

  • Renal disease

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved